Tracking Results of Ablations to Combat AF Registry Generation 2
AtriCure, Inc.
10,000 participants
Feb 1, 2013
OBSERVATIONAL
Conditions
Summary
The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Eligibility
Inclusion Criteria3
- Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s)
- Patient is willing to provide informed consent
- Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law
Exclusion Criteria1
- \. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.
Interventions
AtriCure's Open Concomitant Surgical Ablation Devices used for the management of Atrial Fibrillation.
AtriCure's Hybrid (Convergent) Ablation Devices used for the management of Atrial Fibrillation.
AtriCure's Hybrid Totally Thoracoscopic Surgical Ablation Devices used for the management of Atrial Fibrillation.
AtriCure's LAA Exclusion Devices used to exclude the Left Atrial Appendage for the management of Atrial Fibrillation.
Locations(28)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05111015